* Not logged in  
Login :: Register :: Home 
RSS Feeds :: Classifieds
Contact Us :: About :: Help 
All Categories
Stock Market News 
(Sub Categories)
  By Industry 
  By Company Name 
  By Ticker 
(No Feeds) 		Update update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 4261 failed: 1142 [UPDATE command denied to user '334187_hdlns_ms5'@'10.187.248.89' for table 'feed'] in [update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 4261]
updated 4261 (ALNY (Alnylam Pharmaceuticals Inc)), inserted 0, updated 0, at 2012-05-28 21:11:10
Articles from: ALNY (Alnylam Pharmaceuticals Inc) (MSN Money)  Subscribe
... More from Category: Stock Market News / By Industry / Consumer Non cyclical / Pharmaceuticals / Therapeutics
... More from Category: Stock Market News / By Company Name / A
... More from Category: Stock Market News / By Ticker / A
Previous Page - Next Page  
Alnylam Receives Positive Opinion for Orphan Drug Designation from European (more)2011 02 03
Time to Buy Into Stem Cells? (more)2011 01 31
Alnylam Receives Positive Opinion for Orphan Drug Designation from European (more)2011 01 25
Market Report -- In Play (ALNY) (more)2011 01 25
AstraZeneca Setback on RSV Drug May Spur Deals (more)2011 01 09
Layoffs Mount in 2010: What Does It Mean for 2011? (more)2011 01 06
Alnylam Launches 'Alnylam 5x15' Product Strategy and Provides Guidance and (more)2011 01 06
Alnylam to Webcast Presentation at the 29th Annual J.P. Morgan Healthcare C (more)2011 01 05
Regulus Therapeutics Promotes Garry E. Menzel, Ph.D., to Chief Operating Of (more)2011 01 05
Market Report -- In Play (ALNY) (more)2011 01 05
Market Report -- In Play (ALNY) (more)2011 01 04
Alnylam Demonstrates RNAi in Man with Systemically Delivered RNAi Therapeut (more)2011 01 04
Alnylam Presents New Data on Delivery of RNAi Therapeutics and Human Transl (more)2010 12 16
Market Report -- In Play (ALNY) (more)2010 12 16
U.S. Stock Options With Biggest Changes in Implied Volatility (more)2010 12 15
Alnylam Elects Marsha Fanucci to its Board of Directors (more)2010 12 09
Alnylam to Webcast Presentation at 2010 Deutsche Bank BioFEST (more)2010 12 08
Market Report -- In Play (ALNY) (more)2010 12 02
Alnylam's Tuschl II Patent Fully Upheld in European Opposition Proceedings (more)2010 12 02
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Ap (more)2010 12 02
November's Best- and Worst-Performing Biotech Stocks (more)2010 12 01
RNAi Is On Sale (more)2010 11 30
Alnylam to Webcast Presentation at Piper Jaffray 22nd Annual Healthcare Con (more)2010 11 23
Biotech Sector Weekly Rewind (more)2010 11 20
Alnylam Pharmaceuticals Shares Plunged: What You Need to Know (more)2010 11 18
Alnylam Biotherapeutics Presents Data on New Applications of RNAi Technolog (more)2010 11 18
Market Report -- In Play (ALNY) (more)2010 11 17
Alnylam Comments on Recent Roche Restructuring and Implications for RNAi Th (more)2010 11 17
Alnylam to Webcast Presentation at Lazard Capital Markets 7th Annual Health (more)2010 11 11
Zacks Analyst Blog Highlights: Alnylam Pharmaceuticals, Roche, Novartis, Cu (more)2010 11 11
Market Report -- In Play (ALNY) (more)2010 11 10
Alnylam Presents Additional Interim Phase I Data for ALN-VSP, an RNAi Thera (more)2010 11 10
Alnylam Grants New InterfeRxTM Intellectual Property License to Tekmira for (more)2010 11 04
Alnylam Pharmaceuticals Reports Third Quarter 2010 Financial Results (more)2010 11 03
Regulus Therapeutics Receives Federal Grant Awards for microRNA Therapeutic (more)2010 11 03
Alnylam, Medtronic, and CHDI Foundation Form Collaboration to Advance RNAi (more)2010 11 03
Alnylam Scientists to Present New Data on RNAi Therapeutics at the 61st Ann (more)2010 10 31
Sanofi-Aventis Completes $10 Million Equity Investment in Regulus Therapeut (more)2010 10 28
Alnylam to Webcast Conference Call Discussing Third Quarter 2010 Financial (more)2010 10 27
The War on Cancer: A Long and Ongoing Struggle (more)2010 10 25
Market Report -- In Play (ALNY) (more)2010 10 21
Alnylam Seeks to Prove Skeptics Wrong (more)2010 10 21
Alnylam Seeks to Prove Skeptics Wrong (more)2010 10 21
Regulus Therapeutics Presented New Advancements in microRNA Therapeutics at (more)2010 10 21
Biotech Sector Weekly Rewind (more)2010 10 09
September's Worst Biotech Stocks (more)2010 10 08
Market Report -- In Play (ALNY) (more)2010 10 08
Alnylam Scientists Present New Research on Expanded Delivery of RNAi Therap (more)2010 10 08
Careful What You Wish For, Stem Cell Investors (more)2010 09 29
Alnylam Publishes Results from Phase IIa Study of ALN-RSV01 in the Treatmen (more)2010 09 29
Previous Page - Next Page  


HDLNS (dot com) - News Headlines Updated 24 Hours a Day.
"HDLNS (dot com)" is a trademark of Avant Garde Creatives, Inc. This site, its design, and all associated software © 2005, Avant Garde Creatives, Inc. All rights reserved. All content is provided for your personal, non-commercial use, in accordance with the terms of its providers.
HDLNS (dot com) is search engine sitemap friendly. Classifieds